Effectiveness and Safety of Linezolid as Continuous Infusion Versus Intermittent Infusion in Critically Ill Patients: A Pilot Study
Introduction: Linezolid is a reserve antibiotic used to treat infections caused by Gram-positive bacteria with resistance genes. In critically ill patients, high intra- and interindividual variability has been observed, prompting the search for alternative methods to reduce this variability and achi...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2025-10-01
|
| Serie: | Future Pharmacology |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/2673-9879/5/4/61 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|